GSK Cuts Prices in Indonesia to Boost Sales in Asia

GlaxoSmithKline Plc cut prices on all its drugs sold in Indonesia by 30 to 50 percent this month as part of a plan to raise sales volumes in Asia, which is expected to spend more on healthcare in the years ahead.
London South East